Hydroxyurea, a potential new anti-HIV agent.
Torres
G
G
D004261:DNA Replication / Q000187:drug effects*; D016049:Didanosine / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006678:HIV / Q000502:physiology; D015658:HIV Infections / Q000188:drug therapy*; D006801:Humans; D006918:Hydroxyurea / Q000494:pharmacology* / Q000627:therapeutic use; D007963:Leukocytes, Mononuclear / Q000187:drug effects / Q000821:virology; D014779:Virus Replication / Q000187:drug effects*; D016047:Zalcitabine / Q000627:therapeutic use; D015215:Zidovudine / Q000627:therapeutic use
D015215:Zidovudine; D016047:Zalcitabine; D016049:Didanosine; D006918:Hydroxyurea